Is iFR Reliable After 5 Years? Analyzing the iFR-SWEDEHEART at 5 Years

Fractional flow reserve (FFR) proved to be very useful and safe in the FAME study, but its trade-off was using adenosine (which has a short half-life) and adverse reactions, which fortunately were rare.

¿Es confiable el iFR a 5 años? Análisis del iFR-SWEDEHEART a 5 años

Subsequently, two large studies—the iFR-SWEDEHEART and DEFINE-FLAIR—demonstrated that instantaneous wave-free ratio (iFR) offered comparable results to FFR in the short term, avoiding the use of adenosine, thus lowering costs, procedure time, and the rate of adverse reactions. It also made it somewhat easier to obtain coronary physiology data.

However, the long-term evolution of iFR has not yet been proven.

Researchers performed a 5-year analysis of the iFR-SWEDEHEART study that included 2037 patients with acute or chronic coronary syndromes. Among them, 1019 underwent iFR and 1018 underwent FFR.

There was no difference between populations. The mean age was 67 years, 75% of patients were men, 21% were diabetic, 33% had previous acute myocardial infarction, 42% had undergone a previous angioplasty, and 4% had undergone a previous myocardial revascularization surgery.

Of the subjects studied, 62% had chronic coronary syndrome, 20% had unstable angina, and the rest had non-ST-segment elevation acute myocardial infarction.

Read also: 5-year TVF and MACCE in patients with deferred of revascularization after FFR: Is FFR enough?

Single-vessel lesions were the most frequent type, followed by 2-vessel lesions and, to a lesser extent, 3-vessel lesions.

More lesions were analyzed in patients who underwent iFR compared with those who underwent FFR (1528 vs. 1436; p = 0.002).

After a 5-year follow-up, there were no differences in the composite endpoint of all-cause mortality, non-fatal acute myocardial infarction, or unplanned revascularization (21.5% for iFR vs. 19.9% for FFR; hazard ratio: 1.09; 95% confidence interval: 0.90-1.33). There were also no differences between strategies when analyzing all-cause mortality, non-fatal acute myocardial infarction, or unplanned revascularization.

Conclusion

In patients with acute or chronic coronary syndromes, iFR-guided revascularization offered no difference after a 5-year follow-up in mortality, myocardial infarction, or unplanned revascularization compared with the FFR-guided strategy.

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the editorial board of SOLACI.org .

Original Title: 5-Year Outcomes of PCI Guided by Measurement of Instantaneous Wave-Free Ratio Versus Fractional Flow Reserve.

Reference: Matthias Götberg, et al. J Am Coll Cardiol 2022;79:965–974.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

AHA 2024 | SUMMIT

It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

AHA 2024 – BPROAD

Hypertension (elevated blood pressure, BP) is the most common comorbidity among diabetic patients and has been associated with higher cardiovascular risk, though as a...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...